Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D003864:Depression, Chemical; D003891:Desipramine / Q000494:pharmacology*; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D004357:Drug Synergism; D006834:Hydrazines / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology*; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D010293:Pargyline / Q000494:pharmacology; D013045:Species Specificity; D013268:Stimulation, Chemical; D013464:Sulfuric Acids; D013997:Time Factors; D014316:Tritium
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D013464:Sulfuric Acids; D014316:Tritium; D010293:Pargyline; D007490:Iproniazid; D007099:Imipramine; D003891:Desipramine; D003913:Dextroamphetamine